GIPR expression is induced by thiazolidinediones in a PPARγ-independent manner and repressed by obesogenic stimuli.
GIPR表現受到吲哚二酮類藥物以PPARγ獨立方式誘導,並受肥胖誘發刺激所抑制。
Eur J Cell Biol 2023-06-23
GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease.
GIP受體激動劑在心臟代謝疾病的預臨床小鼠模型中改善血脂異常和動脈粥樣硬化,與體重減輕無關。
Cardiovasc Diabetol 2023-11-21
(D-Ala<sup>2</sup>)GIP Inhibits Inflammatory Bone Resorption by Suppressing TNF-α and RANKL Expression and Directly Impeding Osteoclast Formation.
(D-Ala<sup>2</sup>)GIP通過抑制TNF-α和RANKL表達,並直接阻礙成骨細胞形成,抑制炎性骨吸收。
Int J Mol Sci 2024-03-15
SGLT2i Alleviates Atherosclerosis by Inhibiting NHE1 Activation to Protect against Macrophage Senescence Induced by Angiotensin II.
SGLT2i通過抑制NHE1活化來緩解動脈粥樣硬化,以保護免受由Angiotensin II誘導的巨噬細胞衰老。
Comb Chem High Throughput Screen 2024-05-28
SGLT2 抑制劑有助於對抗動脈硬化,研究指出達帕格列醇可減少老化細胞及斑塊,改善細胞活性,並降低血管緊張素 II 引起的巨噬細胞老化。此外,達帕格列醇也能降低 NHE1 和 SGLT2 的表達,緩解動脈硬化,保護巨噬細胞不受血管緊張素 II 影響。總結來說,SGLT2 抑制劑對於保護血管健康有正面效果。
PubMedDOI
Chronic exposure to incretin metabolites GLP-1(9-36) and GIP(3-42) affect islet morphology and beta cell health in high fat fed mice.
長期暴露於胰高血糖素代謝物GLP-1(9-36)和胰高血糖素激素樣肽(3-42)對高脂飲食小鼠的胰島形態和β細胞健康產生影響。
Peptides 2024-05-30
GIP attenuates neuronal oxidative stress by regulating glucose uptake in spinal cord injury of rat.
GIP透過調節大鼠脊髓損傷中的葡萄糖攝取,減輕神經元氧化壓力。
CNS Neurosci Ther 2024-06-18